Skip to main content
. 2000 Jan;49(Suppl 1):65S–70S. doi: 10.1046/j.1365-2125.2000.00157.x

Figure 1.

Figure 1

Mean serum ziprasidone concentrations in subjects receiving ziprasidone (40 mg day−1) before (day 3) and after (day 28) the administration of placebo or carbamazepine for 21 days. Day 3 group 1 – carbamazepine (•), day 3 group 2 – placebo (○), day 28 group 1 – carbamazepine (▪), day 28 Group 2 – placebo (□).